Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.9T | 16.0T | 16.1T | 14.6T |
Cost of revenue | 13.6T | 13.2T | 13.1T | 11.4T |
Gross profit | 2.3T | 2.8T | 3.0T | 3.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 92.4B | 89.1B | 353.8B | 213.8B |
Other operating expenses | — | -25.4B | 320.8B | — |
Operating income | 1.7T | 1.9T | 1.9T | 2.2T |
Non operating interest income | ||||
Income | 302.2B | 267.4B | 221.2B | 330.9B |
Expense | 301.7B | 110.2B | 405.5B | 274.9B |
Other income expense | — | — | — | — |
Pretax income | 1.7T | 1.9T | 2.4T | 2.3T |
Tax provision | 250.7B | 303.6B | 511.0B | 815.8B |
Net income | 1.5T | 1.6T | 1.8T | 1.4T |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 2.1T | 2.4T | 2.8T | 3.0T |
Net income from continuing op. | — | — | — | — |
Minority interests | -463.7B | -314.7B | -576.9B | -357.9B |
Preferred stock dividends | 0 | 0 | 0 | 0 |